Vaxxinity | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition
3minutes ago
Vaxxinity | 4: Statement of changes in beneficial ownership of securities-Officer Ray Sumita
35minutes ago
Vaxxinity | 25: Notification of the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
47minutes ago
Vaxxinity | 8-K: Current report
Apr 20 04:11
Vaxxinity | 10-K: Annual report
Mar 28 04:20
Vaxxinity | 8-K: Current report
Mar 15 04:25
Vaxxinity | 8-K: Current report
Feb 16 05:19
Vaxxinity | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mei Mei Hu(70.5%)
Feb 13 06:06
Vaxxinity | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lou Reese(9.4%)
Feb 13 06:06
Vaxxinity | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Prime Movers Lab Fund I LP(1.06%),Prime Movers Lab GP I LLC(1.06%), etc.
Feb 8 05:38
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 31 05:08
Vaxxinity | 8-K: Current report
Dec 1, 2023 23:30
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Dec 1, 2023 06:03
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Dec 1, 2023 05:54
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 30, 2023 06:13
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 30, 2023 06:10
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 22, 2023 05:21
Vaxxinity | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 22, 2023 05:20
Vaxxinity: Q3 2023 Earnings Report
Nov 8, 2023 20:53
Vaxxinity | 4: Statement of changes in beneficial ownership of securities-Officer Paula Molina Rene
Nov 4, 2023 04:31
No Data
No Data